These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7184383

  • 41. Neutrophil-mediated tumor cell destruction in cancer ascites.
    Katano M, Torisu M.
    Cancer; 1982 Jul 01; 50(1):62-8. PubMed ID: 7083126
    [Abstract] [Full Text] [Related]

  • 42. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y, Satoh Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Toge T.
    Anticancer Res; 1995 Jul 01; 15(5B):2201-6. PubMed ID: 8572625
    [Abstract] [Full Text] [Related]

  • 43. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
    Terashima M, Takagane A, Abe K, Kuboi M, Asahi H, Saito K.
    Gan To Kagaku Ryoho; 1993 Aug 01; 20(11):1443-5. PubMed ID: 8373202
    [Abstract] [Full Text] [Related]

  • 44. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M, Takashige K, Furuyashiki M, Yoshidome K, Sano R, Kawamura Y, Ijichi S, Morioka H, Koide H, Oku N, Moriya Y, Kusumoto S, Suda Y.
    Int Immunopharmacol; 2008 Jan 01; 8(1):12-9. PubMed ID: 18068095
    [Abstract] [Full Text] [Related]

  • 45. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
    Satoh S, Suzuki A, Okamura H, Nishimura T.
    Gan To Kagaku Ryoho; 1982 Jan 01; 9(1):140-5. PubMed ID: 6820877
    [Abstract] [Full Text] [Related]

  • 46. Simultaneous intraperitoneal administration of OK-432 and serum enhances superoxide generation from migrated polymorphonuclear leukocytes, with special emphasis on the role of complements.
    Yoshikawa T, Takano H, Yoshida N, Kondo M.
    Immunopharmacol Immunotoxicol; 1995 May 01; 17(2):265-82. PubMed ID: 7650290
    [Abstract] [Full Text] [Related]

  • 47. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
    Fujimura T, Torisu M.
    Clin Immunol Immunopathol; 1987 May 01; 43(2):174-84. PubMed ID: 3105938
    [Abstract] [Full Text] [Related]

  • 48. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.
    Fukui H, Reynolds CW, Lenz B, Schneider M, Talmadge JE.
    Cancer Immunol Immunother; 1989 May 01; 29(1):1-6. PubMed ID: 2784999
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Yamada Y, Tamaya T.
    Asia Oceania J Obstet Gynaecol; 1989 Sep 01; 15(3):281-9. PubMed ID: 2512905
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.
    Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356
    [Abstract] [Full Text] [Related]

  • 54. [Combined effect of cis-DDP (II), OK-432 and systemic hyperthermia in ascites tumor in mice].
    Komatsu K, Nakamura W.
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar 20; 24(3):626-37. PubMed ID: 2504850
    [Abstract] [Full Text] [Related]

  • 55. [Antitumor effect of direct intra-tumor administration of OK-432 on malignant glioma: basic and clinical observations].
    Fujisawa K, Kanno T, Yokoi K, Onouchi K, Kawase T, Abe M.
    No Shinkei Geka; 1991 Mar 20; 19(3):241-6. PubMed ID: 2038413
    [Abstract] [Full Text] [Related]

  • 56. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
    Takada T, Yasuda H, Uchiyama K, Hasegawa H, Miura S, Asagoe T, Hanaue H, Shikata J.
    Gan To Kagaku Ryoho; 1985 Dec 20; 12(12):2305-13. PubMed ID: 2934024
    [Abstract] [Full Text] [Related]

  • 57. [Immunochemotherapy of carcinomatous peritonitis and pleuritis--report of 2 cases].
    Takekoshi H, Yoshida K, Morinaga S.
    Gan To Kagaku Ryoho; 1992 Aug 20; 19(10 Suppl):1466-9. PubMed ID: 1326910
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
    Kato H, Inoue M, Yamamura Y, Tanigawa M, Sano H, Sugino S, Kondo M.
    Nat Immun Cell Growth Regul; 1989 Aug 20; 8(5):290-300. PubMed ID: 2512482
    [Abstract] [Full Text] [Related]

  • 60. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
    Kawano Y, Watanabe M, Kubota T, Nishibori H, Kurihara N, Teramoto T, Kitajima M.
    Anticancer Res; 1997 Aug 20; 17(4A):2449-53. PubMed ID: 9252661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.